Case Studies

Coronavirus Vaccine Study

Background:
US biotech company selected Paratus Clinical to be involved in a Phase 1/2 trial of a COVID-19 vaccine in healthy adults 18-59 years of age.

Requirement:
The ultimate goal of the Sponsor company was to allow rapid advancement during the current coronavirus pandemic.

Outcome:

Paratus was the first Australian site activated and first to randomise a participant for Phase 2 trial.
Site staff proved their flexibility and adaptability when Sponsor recruitment targets changed.
100% compliance to the study requirement of 24 hour data entry.
Paratus Clinical's quality of participants, flexibility and speed contributed to the quick development of the vaccine.

Background:

A small biotech company working with an Australian CRO looking for a site capable of long patient visits for their Ph2a Gout study.

Requirement:

The study required 9 PK samples across a 10 hour period with no overnight stay.

Outcome:

Patients were onsite for 12 hours +
Patients were constantly monitored by site staff throughout this period
Patients were provided with office space to work from, lunch and drink vouchers for local cafes and entertainment to fill in their time

Hypercholesterolemia Study

Background:

A Sponsor company working with an Australian CRO selected Paratus Clinical to be involved in a Hypercholesterolemia study for 20-80 year olds.

Requirement:

The initial study recruitment timeline was reduced and Paratus Clinical was requested to recruit more patients to ensure target was met.

Outcome:

Huge patient interest from our recruitment advertising
Paratus Clinical exceeded recruitment target
Recruitment completed in 23 days, Sponsor timelines met

Influenza Vaccine for Over-50 Year Olds

Background:

A global influenza vaccine company working with an Australian CRO looking for a Southern Hemisphere site for an Influenza study.

Requirement:

Study required 24 healthy volunteers over the age of 50 to be recruited 1 month prior to Australian flu season starting.

Outcome:

Age range of participants and delay in study start up proved challenging for recruitment
3 Paratus sites recruited 80 participants in 7 weeks, this more than exceeded target
Sponsor and CRO impressed with quality of patient data and study outcomes

Cytomegalovirus Vaccine

Background:

A multinational pharmaceutical company needed to speed up development timelines for a new vaccine study.

Requirement:

The pharmaceutical company selected five sites in Australia (two from Paratus Clinical).Each site needed to recruit 12 women aged between 16-30 years of age.

Outcome:

Paratus recruited 78% of Australian participants.
Study recruitment closed on time.
Speedy development of vaccine occurred.

Influenza Detection Diagnostic

Background:

An Australian biotech company had developed a new point-of-care diagnostic to detect influenza and needed access to patients with ‘influenza-like illnesses’ within72 hours of symptom onset.

Requirement:

Paratus worked closely with partner GP practices to set up referral pathways for eligible and interested patients, as well as setting up inside a GP practice to accommodate the study.

Outcome:

Paratus recruited over 150 patients.
The study was able to proceed with a statistically relevant number of patients.
Development of the diagnostic tool was able to continue.

New Migraine Treatment

Background:

An Australian biotech developing a new migraine treatment had experienced difficulty in achieving successful patient recruitment.

Requirement:

The biotech company required fast recruitment after experiencing previous delays.

Outcome:

Paratus delivered 120% of target in two months
The biotech company was able to progress research to the next stage of development more rapidly than anticipated

Phase II Flu Vaccine Study

Background:

A UK-based biotech company working with an Australian CRO required fast recruitment for a Phase II flu vaccine study.

Requirement:

Biotech company needed 2,200 healthy volunteers during the 2019 flu season.

Outcome:

Paratus recruited 893 participants (more than double the initial target).
Fast recruitment expectations were accomplished.
Paratus Western Sydney clinic was the highest recruiting site.

Choose Paratus Clinical for your important clinical research study to provide the best possible chance of success.

Slow participant recruitment is the number 1 limiting factor for clinical research.

Dedicated research recruitment team

Multiple pathways to recruitment

Large, engaged database at all clinical locations

Digital advertising campaigns

Established referral network

GPs, Specialists, Pharmacy, Community outreach, Third-party companies

Are you interested in participating in clinical trials?

Register your interest, and we'll notify you of any upcoming trials that might be suitable for you.
We value your privacy and are committed to protecting your data and personal information.

Giving your trial the best chance of success

Coronavirus Vaccine Study

Gout PK Samples

Background:

Requirement:

Outcome:

Hypercholesterolemia Study

Background:

Requirement:

Outcome:

Influenza Vaccine for Over-50 Year Olds

Background:

Requirement:

Outcome:

Cytomegalovirus Vaccine

Background:

Requirement:

Outcome:

Influenza Detection Diagnostic

Background:

Requirement:

Outcome:

New Migraine Treatment

Background:

Requirement:

Outcome:

Phase II Flu Vaccine Study

Background:

Requirement:

Outcome:

Choose Paratus Clinical for your important clinical research study to provide the best possible chance of success.

Dedicated research recruitment team

Multiple pathways to recruitment

Large, engaged database at all clinical locations

Digital advertising campaigns

Established referral network

Are you interested in participating in clinical trials?

Navigation

Locations